API - Active Pharmaceutical Ingredients

Product Name

Therapeutic Use

Cas No

More

Sartaline

Anti Depressant

79617-96-2

Developed

Ezetimibe

Lipid – Lowering

163222-33-1

Developed

Voriconazole

Anti-Fungal

137234-62-9

Developed

Terbinafine

Anti-Fungal

91161-71-6

Developed

Sofosbuvir

Anti – viral

1190307-88-0

Developed

Ribavirin

Anti – viral

36791-04-5

Developed

AcicIovir

Anti – viral

59277-89-3

Developed

Entecavir

Anti – viral

142217-69-4

Developed

Tenofovir Alafenamide Fumarate

Anti – viral

1392275-56-7

Developed

Ledipasvir

Anti – viral

1256388-51-8

Developed

Oseltamivir phosphate

Anti – viral

204255-11-8

Developed

Velpatasvir

Anti – viral

1377049-84-7

Developed

Favipiravir

Anti – viral

259793-96-9

Developed

Remdesivir

Anti – viral

1809249-37-3

Developed

Baloxavir marboxil

Anti – viral

1985606-14-1

Developed

Tenofovir Disoproxil Fumarate

Anti – viral

147127-20-6

Developed

Cefazolin sodium

Antibiotic

27164-46-1

Developed

Azithromycin

Antibiotic

83905-01-5

Developed

Ciprofloxacin

Antibiotic

85721-33-1

Developed

Clindamycin HCL

Antibiotic

21462-39-5

Developed

Abiraterone Acetate

Anti-Cancer

154229-18-2

Developed

Acalabrutinib

Anti-Cancer

1420477-60-6

Developed

Trastuzumab

Anti-Cancer

180288-69-1

Developed

Brigatinib

Anti-Cancer

1197953-54-0

Developed

Dacarbazine

Anti-Cancer

4342-03-4

Developed

Sorafenib

Anti-Cancer

284461-73-0

Developed

Crizotinib

Anti-Cancer

877399-52-5

Developed

Lapatinib

Anti-Cancer

388082-78-8

Developed

Neratinib

Anti-Cancer

698387-09-6

Developed

Ceritinib

Anti-Cancer

1032900-25-6

Developed

Olaparib

Anti-Cancer

763113-22-0

Developed

Osimertinib

Anti-Cancer

1421373-65-0

Developed

Gefitinib

Anti-Cancer

184475-35-2

Developed

Imatinib

Anti-Cancer

152459-95-5

Developed

Venetoclax

Anti-Cancer

1257044-40-8

Developed

Cabozantinib

Anti-Cancer

849217-68-1

Developed

Ibrutinib

Anti-Cancer

936563-96-1

Developed

Regorafenib

Anti-Cancer

755037-03-7

Developed

Palbocicilib

Anti-Cancer

827022-32-2

Developed

Pazopanib

Anti-Cancer

444731-52-6

Developed

Nilotinib

Anti-Cancer

641571-10-0

Developed

Larotrectinib Sulfate

Anti-Cancer

1223405-08-0

Developed

Ruxolitinib

Anti-Cancer

941678-49-5

Developed

Rupacarib

Anti-Cancer

283173-50-2

Developed

Lorlatinib

Anti-Cancer

1454846-35-5

Developed

Afatinib

Anti-Cancer

439081-18-2

Developed

Lenvatinib

Anti-Cancer

417716-92-8

Developed

Sunitinib

Anti-Cancer

557795-19-4

Developed

Tofacitinib Citrate

Anti-Cancer

540737-29-9

Developed

Temozolomide

Anti-Cancer

85622-93-1

Developed

Apixaben

Cardiovascular

503612-47-3

Developed

Valsartan

Cardiovascular

137862-53-4

Developed

Ticagrelor

Cardiovascular

274693-27-5

Developed

Rivaroxaban

Cardiovascular

366789-02-8

Developed

Amlodipine

Cardiovascular

88150-42-9

Developed

Eplerenone

Cardiovascular

107724-20-9

Developed

Atorvastatin Calcium

Cardiovascular

134523-00-5

Developed

Rosuvastatin Calcium

Cardiovascular

147098-20-2

Developed

Hydrochlorothiazide

Cardiovascular

58-93-5

Developed

Nebivolol Hydrochloride 

Cardiovascular

152520-56-4

Developed

Rupatadine

Anti Histamine

158876-82-5

Developed

Fexofenadine

Anti Histamine

83799-24-0

Developed

Ambroxol Hydrochloride

Anti Histamine

23828-92-4

Developed

Diclofenac

Anti Histamine

15307-86-5

Developed

Naproxen

Anti Histamine

22204-53-1

Developed

Sitagliptin

Anti-Diabetics

486460-32-6

Developed

Vildagliptin

Anti-Diabetics

274901-16-5

Developed

Saxagliptin 

Anti-Diabetics

361442-04-8

Developed

Linagliptin 

Anti-Diabetics

668270-12-0

Developed

Trelagliptin Succinate

Anti-Diabetics

1029877-94-8

Developed

Gliclazide

Anti-Diabetics

21187-98-4

Developed

Glimepiride

Anti-Diabetics

93479-97-1

Developed

Tamsulosin Hydrochloride

Urology

106463-17-6

Developed

Omeprazole Sodium Fine Powder

Anti-Ulcerate

73590-58-6

Developed

Esomeprazole magnesium

Anti-Ulcerate

217087-09-7

Developed

Omeprazole 8.5 %w/w EC Pellets 

Anti-Ulcerate

 

Developed

Esomeprazole 8.5 %w/w EC Pellets

Anti-Ulcerate

161973-10-0

Developed

Product Name

Therapeutic Use

Cas No

More

Voxilaprevir

Anti – viral


1535212-07-7

Underdevelopment

Penciclovir

Anti – viral

39809-25-1

Underdevelopment

Valaciclovir

Anti – viral

124832-27-5

Underdevelopment

Interferon Alfa

Anti – viral

98530-12-2

Underdevelopment

Silodosin INN

Urology

160970-54-7

Underdevelopment

Ceftriaxone Sodium

Antibiotic

104376-79-6)

Underdevelopment

Ceftibuten Dihydrate

Antibiotic

118081-34-8

Underdevelopment

Cefoperazone

Antibiotic

62893-19-0

Underdevelopment

Clavulanic Acid

Antibiotic

58001-44-8

Underdevelopment

Cefepime

Antibiotic

88040-23-7

Underdevelopment

Ceftazidime

Antibiotic

72558-82-8

Underdevelopment

Maropenem

Antibiotic

119478-56-7

Underdevelopment

Gamifloxacin 

Antibiotic

175463-14-6

Underdevelopment

Levofloxacin

Antibiotic

100986-85-4

Underdevelopment

Pefloxacin

Antibiotic

70458-92-3

Underdevelopment

Sparfloxacin

Antibiotic

110871-86-8

Underdevelopment

Rifaximin

Antibiotic

80621-81-4

Underdevelopment

Vancomycin HCL

Antibiotic

1404-93-9

Underdevelopment

Imipenem

Antibiotic

74431-23-5

Underdevelopment

Mupirocin

Antibiotic

12650-69-0

Underdevelopment

Clarithromycin

Antibiotic

81103-11-9

Underdevelopment

Erdafitinib

Anti-Cancer

1346242-81-6

Underdevelopment

Avatrombopag

Anti-Cancer

570406-98

Underdevelopment

Rituximab

Anti-Cancer

174722-31-7

Underdevelopment

Alpelisib

Anti-Cancer

1217486-61-7

Underdevelopment

Upadacitinib

Anti-Cancer

1310726-60-3

Underdevelopment

Axitinib

Anti-Cancer

319460-85-0

Underdevelopment

Entrecetinib

Anti-Cancer

1108743-60.

Underdevelopment

Pomalidomide

Anti-Cancer

19171-19-8

Underdevelopment

Bosutinib

Anti-Cancer

380843-75-4

Underdevelopment

Nindetinib

Anti-Cancer

656247-17-5

Underdevelopment

Dasatinib

Anti-Cancer

302962-49-8

Underdevelopment

Selpercatinib

Anti-Cancer

2152628-33-4

Underdevelopment

Capmatinib

Anti-Cancer

1029712-80-8

Underdevelopment

Tucatinib

Anti-Cancer

937263-43-9

Underdevelopment

Ripretinib

Anti-Cancer

1442472-39-0

Underdevelopment

Relugolix

Anti-Cancer


737789-87-6

Underdevelopment

Cetuximab

Anti-Cancer

205923-56-4

Underdevelopment

Bevacizumab

Anti-Cancer

216974-75-3

Underdevelopment

Apalutamide

Anti-Cancer

956104-40-8

Underdevelopment

Adalimumab

Anti-Cancer

331731-18-1

Underdevelopment

Telmisartan 

Cardiovascular

144701-48-4

Underdevelopment

Olmesartan Medoxmil

Cardiovascular

144689-63-4

Underdevelopment

Losartan

Cardiovascular

114798-26-4

Underdevelopment

Enoxaparin Sodium

Cardiovascular

114798-26-4

Underdevelopment

Heparin Sodium 

Cardiovascular

9041-08-1

Underdevelopment

Bisoprolol Fumarate 

Cardiovascular

66722-44-9

Underdevelopment

Trimitazidine HCL

Cardiovascular

13171-25-0

Underdevelopment

Loratidine

Anti Histamine

79794-75-5

Underdevelopment

Desloratidine

Anti Histamine

100643-71-8

Underdevelopment

Ketotifen

Anti Histamine

34580-14-8

Underdevelopment

Levocetirizine 

Anti Histamine

130018-77-8

Underdevelopment

Naproxen Sodium

Anti Histamine

22204-53-1

Underdevelopment

Fexofenadine HCl

Anti Histamine

83799-24-0

Underdevelopment

Alogliptin

Anti-Diabetics

850649-62-6

Underdevelopment